The fractalkine receptor CX3CR1 is a key mediator of atherogenesis
- PMID: 12697729
- PMCID: PMC152943
- DOI: 10.1172/JCI18237
The fractalkine receptor CX3CR1 is a key mediator of atherogenesis
Figures
Comment on
-
Decreased atherosclerosis in CX3CR1-/- mice reveals a role for fractalkine in atherogenesis.J Clin Invest. 2003 Feb;111(3):333-40. doi: 10.1172/JCI15555. J Clin Invest. 2003. PMID: 12569158 Free PMC article.
-
Chemokine receptor mutant CX3CR1-M280 has impaired adhesive function and correlates with protection from cardiovascular disease in humans.J Clin Invest. 2003 Apr;111(8):1241-50. doi: 10.1172/JCI16790. J Clin Invest. 2003. PMID: 12697743 Free PMC article.
References
-
- Bazan JF, et al. A new class of membrane-bound chemokine with a CX3C motif. Nature. 1997;385:640–644. - PubMed
-
- Pan Y, et al. Neurotactin, a membrane-anchored chemokine upregulated in brain inflammation. Nature. 1997;387:611–617. - PubMed
-
- Imai T, et al. Identification and molecular characterization of fractalkine receptor CX3CR1, which mediates both leukocyte migration and adhesion. Cell. 1997;91:521–530. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous
